Psychotic disorders are severe mental health disorders that cause changes in a person's way of thinking and their perception. Patients often have trouble differentiating between what they perceive and reality. Different types of psychotic disorders include schizophrenia, bipolar disorder, substance-induced psychotic disorder, delusional disorder, and brief psychotic disorder. However, this market only represents the sales of antipsychotic drugs that are used to treat schizophrenia and bipolar disorder.
Market values represent the revenues generated by manufacturers and are based on retail prices for each drug category including all drugs, regardless of whether they are reimbursed or not.
Company examples: Otsuka Pharmaceutical, Lundbeck, AbbVie, Allergan plc, Recordati S.p.A., Gadeon Richter, Sumitomo Pharma, Johnson & Johnson / Janssen, Vanda Pharmaceuticals, Alkermes, Eli Lilly, AstraZeneca, and Intra-Cellular Therapies
Notes: Data was converted from local currencies using average exchange rates of the respective year.
Most recent update: Jun 2024
Source: Statista Market Insights
Most recent update: Jun 2024
Source: Statista Market Insights
Most recent update: Jun 2024
Source: Statista Market Insights
The Psychotic Disorders market in Sri Lanka is experiencing significant growth and development due to several factors.
Customer preferences: Customers in Sri Lanka are increasingly seeking effective treatment options for psychotic disorders. They are becoming more aware of the importance of mental health and are actively seeking medical help for themselves or their loved ones. This increased demand for treatment options has contributed to the growth of the Psychotic Disorders market in Sri Lanka.
Trends in the market: One of the key trends in the Psychotic Disorders market in Sri Lanka is the adoption of innovative treatment methods. Healthcare providers are increasingly using advanced therapies and medications to effectively manage psychotic disorders. This includes the use of antipsychotic medications, psychotherapy, and other non-pharmacological interventions. The trend towards personalized medicine is also gaining traction, with healthcare providers tailoring treatment plans to individual patients based on their specific needs and circumstances.
Local special circumstances: Sri Lanka has a relatively high prevalence of mental health disorders, including psychotic disorders. This is partly due to the country's history of conflict and natural disasters, which have had a significant impact on the mental well-being of the population. The government and healthcare organizations in Sri Lanka have recognized the importance of addressing mental health issues and have taken steps to improve access to mental health services. This includes the establishment of specialized mental health clinics and the training of healthcare professionals in the diagnosis and treatment of psychotic disorders.
Underlying macroeconomic factors: The growing Psychotic Disorders market in Sri Lanka is also influenced by underlying macroeconomic factors. The country's economic growth and increasing disposable income have resulted in improved access to healthcare services for the population. This has allowed more individuals to seek treatment for mental health issues, including psychotic disorders. Additionally, the government's focus on healthcare infrastructure development and the expansion of health insurance coverage have further facilitated the growth of the Psychotic Disorders market in Sri Lanka.In conclusion, the Psychotic Disorders market in Sri Lanka is experiencing significant growth and development due to increasing customer preferences for effective treatment options, the adoption of innovative treatment methods, local special circumstances related to mental health, and underlying macroeconomic factors. This growth is expected to continue as the importance of mental health is increasingly recognized and addressed in Sri Lanka.
Most recent update: Jun 2024
Source: Statista Market Insights
Data coverage:
Data encompasses B2C enterprises. Figures are based on companies' revenues, international institutes data, and global consumer survey data. Revenues refer to the retail value and include sales taxes.Modeling approach / Market size:
Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use financial reports and third-party data. Next, we use relevant key market indicators and data from country-specific associations such as healthcare spending per capita, medical product spending per capita, and gross domestic product per capita. This data helps us to estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, S-Curve function, ARIMA time series model and exponential curve function. Data is modeled using current exchange rates.Additional Notes:
The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. GCS data is reweighted for representativeness.Notes: Based on data from IMF, World Bank, UN and Eurostat
Most recent update: Sep 2024
Source: Statista Market Insights